Edition:
United Kingdom

Sienna Biopharmaceuticals Inc (SNNA.OQ)

SNNA.OQ on NASDAQ Stock Exchange Global Select Market

24.09USD
4:42pm GMT
Change (% chg)

$-0.21 (-0.86%)
Prev Close
$24.30
Open
$24.34
Day's High
$24.55
Day's Low
$23.93
Volume
7,230
Avg. Vol
24,844
52-wk High
$28.95
52-wk Low
$17.42

Chart for

About

Sienna Biopharmaceuticals, Inc. is a United States-based medical dermatology and aesthetics company. The Company focuses on developing targeted therapies to treat inflammatory skin conditions and aesthetic concerns that impact the health and appearance of patients. Its research and clinical-stage candidates include programs,... (more)

Overall

Beta: --
Market Cap(Mil.): $481.46
Shares Outstanding(Mil.): 20.53
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Sienna Biopharmaceuticals posts qtrly loss per share $1.12‍​

* Sienna Biopharmaceuticals reports third quarter 2017 financial results

09 Nov 2017

BRIEF-Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

* Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

24 Oct 2017

BRIEF-Sienna Biopharmaceuticals reports Q2 loss of $6.50/shr

* Sienna Biopharmaceuticals reports second quarter 2017 financial results

07 Sep 2017

BRIEF-Partner Fund reports 7.7 pct passive stake in Sienna Biopharmaceuticals‍​

* Partner Fund Management LP reports 7.7 percent passive stake in Sienna Biopharmaceuticals Inc as of July 27, 2017 - SEC filing‍​ Source text: (http://bit.ly/2vfsuuL) Further company coverage:

07 Aug 2017

BRIEF-Sienna Biopharmaceuticals shares open 27 pct above IPO price in debut

* Sienna Biopharmaceuticals Inc shares open at $19.05 in debut on the NASDAQ versus IPO price of $15.00

27 Jul 2017

Earnings vs. Estimates